5 Stocks With Bad Analyst Earnings Revisions — GLYC AMCC SOL MSO IFT

This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

GLYC also gets F’s in Equity and Sales Growth. For more information, get Portfolio Grader’s complete analysis of GLYC stock.

Applied Micro Circuits Corporation (AMCC) provides semiconductor solutions for the enterprise, telecom and consumer/small medium business (SMB) markets. AMCC also gets F’s in Earnings Momentum, Equity and Sales Growth. For more information, get Portfolio Grader’s complete analysis of AMCC stock.

ReneSola Ltd. Sponsored ADR (SOL) develops, manufactures and sells solar wafers, which are thin sheets of crystalline silicon material mainly made by slicing monocrystalline or multicrystalline ingots. SOL gets F’s in Equity and Cash Flow as well. Since January 1, SOL has fallen 18.8%. This is worse than the S&P 500, which has remained flat. For more information, get Portfolio Grader’s complete analysis of SOL stock.

Martha Stewart Living Omnimedia, Inc. (MSO) creates original how-to content and related products for homemakers and other consumers. MSO also gets an F in Sales Growth. Since January 1, MSO has fallen 2.3%. For more information, get Portfolio Grader’s complete analysis of MSO stock.

Imperial Holdings, Inc. (IFT) is a specialty finance company with a focus on providing financing for individual life insurance policies and purchasing structured settlements. IFT also gets F’s in Earnings Growth, Earnings Momentum, Operating Margin Growth and Sales Growth. The stock currently has a trailing PE Ratio of 91.00. For more information, get Portfolio Grader’s complete analysis of IFT stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/01/5-stocks-with-bad-analyst-earnings-revisions-glyc-amcc-sol-mso-ift-glyc-amcc-sol/.

©2021 InvestorPlace Media, LLC